Director & Professor, Sechenov University
Sergey Suchkov, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia.Director, Center for Personalized Medicine and Professor, Department of Pathology, Sechenov University, worked at Inst of Med Enzymology, USSR Academy of Medical Sciences, senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences, Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Inst in Moscow, Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. He is a member of the Editorial Boards of many international journals
CEO & Cofounder, Varigen Biosciences
David Mead is CEO and Co-Founder of Varigen Biosciences Corp and founder of Lucigen Corp. Dr. Mead earned a Ph.D. in Physiology and Biophysics at the University of Illinois–Champaign/Urbana, and is co-author of sixty publications, co-inventor on ten patents, and the inventor of TA cloning.
Principal Scientist at Biogen,
Istvan J Enyedy has been working at Biogen Idec, in Cambridge MA. He received his PhD in 1998 at Catholic University of America, Washington DC, and did postdoctoral training in Dr. Shaomeng Wang’s group at Georgetown University Medical Center, Washington DC. Between 2001 and 2008 he worked at Bayer Pharmaceuticals, West Haven CT and Novartis Institutes for Biomedical Research in Cambridge MA. In the past 21 years Istvan J Enyedy has been involved in new target evaluation, hit finding, and hit-to-lead optimization projects for several types of target classes using both ligand and structure-based methods. He is coauthor on more than 50 publications and 14 patents/applications.
Founder and CEO of the Center for Advancing Innovation (CAI)
Rosemarie Truman is an entrepreneur, growth strategist, distinguished corporate executive, angel investor and prolific startup catalyst. Rosemarie’s specialty is growth and investment strategy, having led growth strategies for 50 of the global Fortune 100 companies in over 15 countries. Under Rosemarie’s leadership, CAI has earned numerous awards and recognition from Health and Human Services, the White House, the Federal Laboratory Consortium and more. Rosemarie also serves as Director of the DC-metro chapter of the Founder Institute, the world’s largest startup accelerator program and severs on multiple boards such as Mindshare. Mindshare is an exclusive, invitation-only network of chief executive officers (CEOs) from the most promising emerging and high growth technology companies. Prior to launching her own firm, Rosemarie spearheaded IBM’s Innovation strategy practice globally. At IBM, she was awarded IBM’s most laudable honor, the Golden Circle Award. In addition, she has also held notable leadership roles at Booz Allen Hamilton, Oracle, PRTM, and Marsh & McLennan, where she served as VP of global strategy. Rosemarie began her career at Goldman Sachs. Her core competencies are in leadership, strategy consulting, investment banking and entrepreneurship.
Professor, Gazi University
Prof.Dr. Esra KÜPELI AKKOL was born in Turkey. She got her Bachelor of Science degree in Faculty of Pharmacy, Gazi University, Turkey and got her Ph.D. degree in Pharmacognosy Department from the University of Gazi. She is currently Professor in the Gazi University, Faculty of Pharmacy, Department of Pharmacognosy. She served in many capacities in her field including service on several editorial boards and numerous review committees for journals such as Journal of Ethnopharmacology, Journal of Pharmacy Sciences, The Internet Journal of Herbal and Plant Medicine, International Journal of Genuine Traditional Medicine, Advances in Pharmacological Sciences, Evidence Based Complementary Alternative Medicine and The Open Pain Journal. She has conducted 48 projects and 15 thesis in Gazi University. She has 180 published articles in SCI International Journals, 13 articles in National Journals and 10 chapters in International books.
Professor, The University of Sunderland
Professor Elkordy has a degree in Pharmacy and an MPhil in Pharmaceutical Technology, She earned her PhD in Pharmaceutical Technology from the School of Pharmacy, University of Bradford, UK.She published a significant number of papers on various fields of pharmaceutics, evident from over 120 publications including journal articles and conference papers. She is currently supervising a number of PhD students. Her research is reflected in teaching and accordingly, based on her experience in formulations of both small and large drug molecules. She designed MSc Pharmaceutical and BioPharmaceutical Formulations which is one of the few Masters courses in the UK that covers biopharmaceuticals as well as pharmaceuticals.She is a book editor, an editorial board member for some journals in pharmaceutical sciences and a reviewer for several national and international pharmaceutics journals. She presented keynote and invited speeches at different conferences worldwide. Professor Elkordy also chair scientific sessions at national and international pharmaceutical conferences.
University of Mumbai
Dr. Seema Habib Isa has completed her Ph.D. at the age of 33 years from the Swami Ramanand Teerth Marathwada University, Nanded, Maharashtra, India. Awarded with Honorary Degree of Doctor of Science for outstanding Scientific Contribution in Chemisty by International Agency for standards and Ratings. Awarded the Prestigious Adarsh Saraswati Rashtriya Puraskar by Global Management Council of Glacier Journal Research Foundation, Ahmadabad, Gujarat. She is a Fellow of the International Association of the Science Impact (F.I.A.S.I), published more than 47 papers in reputed journals and has been serving as an Editorial Board Member of the National Journals and International Journals. Her area of research interest is Organic Synthesis and its applications to Inorganic Synthesis.
University of Basilicata
PhD in Pharmaceutical Sciences from University of Naples, Postgraduate from University of Naples Hospital Pharmacy. Completed his Degree in Pharmacy in University of Naple. Fellow of the pharmaceutical industry -Servier in Paris and later the University of Caen (F). Worked as an Associate Professor in Medicinal Chemistry in University of Salerno and University of Basilicata. Co-Founding member and Director of an academic spin. Qualified to Full Professor in Chemical Foundations of Technologies and Medicinal Chemistry. He was a Co-author of over 100 papers in international scientific journals indexed on Scopus/ISI. Co-author of 6 patents, some of which are PCT. Over 230 communications at national and international conferences. He has won several awards and research awards
Dr. Dinesh Jaiswal, In his professional tenure, he has successfully filed a patent, published and reviewed several articles in reputed high impact international journals, supported the filing of more than 20 ANDAs, and developed CM&Cs for more than 7 launched products. Furthermore, he has delivered several invited talks and presented posters at several conferences and meetings globally. He was also the Chairman of the Organizing Committee, Honorable Guest Speaker of Society of Pharmaceutical Education & Research (SPER) and successfully organized 6th Annual International Conference & Exhibition held on March, 2017 at Jaipur National University, Jaipur, India. He worked with SPER, to not only promote the ethical standards of pharmacy but also to raise the growth, development, and betterment of the pharmacy arena.Dr. Jaiswal is actively affiliated with the American Association of Pharmaceutical Scientists (AAPS) for more than 25 years and serves as a reviewer of journal articles related to Pharmaceutical Technology. He was also a member of Parenteral Drug Association (PDA) and the International Society of Pharmaceutical Engineers (ISPE).
CEU Cardenal Herrera University
Dr. Lopez-Ruiz has completed her Ph.D. from Valencia University and postdoctoral studies from CEU Cardenal Herrera Health Sciences Faculty. She obtained her doctorate in Medicine with the doctoral thesis on “Analysis of the use of medication in the pediatric population that visit accident and emergency department” with Summa Cum Laude. She has achieved the qualification of “University Expert in Neonatology” from the Catholic University in Valencia and “Master’s Degree in Neonatology (from de SENeo -Neonatology Spanish Society-)”. She is Medicine Degree Coordinator at CEU Cardenal Herrera University since 2015. She is the director of the “Master’s degree in Neonatal Intensive care and Neonatal Nursing”. She has attended to International Congresses of Pediatrics as a keynote speaker and she has been part of the Organizing Committee member for the 12th International Conference on Pediatric Pathology and Laboratory Medicine, for the 11th International Conference and Exhibition on Pharmacovigilance & Drug Safety and for the 17th International Conference on Pathology and Cancer Epidemiology. One of her latest publications is “Self-Medication: a Major Problem Worldwide that Could be Prevented”.
California Innovations Corporation, CA
Dr. Farid Menaa,Professor, Director and Independent Consultant, Departments of Internal Medicine and Nanomedicine, California Innovations Corporation, CA, USA. Worked as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.
Research Institute of Forests and RangeLands
Mohammad bagher Rezaee is an Iranian scientist. He did PhD. and Research work on Photochemistry. And personal life doing research with our co-worker on identification, cultivation, extraction and few formulation of natural products from medicinal and aromatic plants. So for designed research and pilot distillation apparatuses for essential oil and herbal extraction. Published 6 Books on this subjects in Persian language in Iran and international chapters on bio-activity of herbal extracts and essential oil. Nearly 70 projects with MSc. and PhD thesis students. Published more than 250 papers on this and related topic, in national and international (ISI) journals. Know His position are as scientist in Research Institute Forests and Rangelands (RIFR), Chairman of "Union Medicinal plants of Iran" (UMPI) and chair member of "Iranian medicinal plants society" (IMPS).Dr.Razaee got three national award abut selected and important medicinal plant as natural product or instead of synthetic medicine and bio-logical uses. And so on…
Director, Bio-Mimetic Chromatography Ltd
Klara Valko has completed his PhD at the age of 26 years from Semmelweis University and postdoctoral studies from Yale University, CT, USA. After working at GSK for 22 years now she is the director of Bio-Mimetic Chromatography Ltd, providing consultations and measurement services for biotech companies involved in drug discovery. She is also an honorary professor at UCL School of Pharmacy where he teaches the Physchem/ADME module for Drug Discovery and Pharma Management master course. She has published more than 100 papers in reputed journals and has been serving as an editorial board member of ADMET&DMPK journal. She is a Fellow of the Royal Society of Chemistry.
Dr. Brahim Benyahia is an Associate Professor at the Department of Chemical Engineering, Loughborough University, UK. Currently a member of the EPSRC’s Future Manufacturing Hub for Continuous Manufacturing and Advanced Crystallisation - CMAC HUB as well as ARTICULAR (ARtificial inTelligence for Integrated ICT-enabled pharmaceUticaL mAnufactuRing). He has well-established expertise in Integrated End-to-End Continuous Pharmaceutical Manufacturing; Quality-by-Design; Plant-Wide Modelling and Optimization; Process and Plant-Wide Control; Multicriteria Decision Aiding and Sustainable Production Systems (Life Cycle Assessment and Green Engineering). He played a key role in the development of the first End-to-End Integrated Continuous Pharmaceutical Manufacturing Platform at MIT, USA (a $65 M Novartis-MIT project). He was the recipient and co-recipient of several awards including the MIT’s Outstanding Contribution Award and the Council for Chemical Research Collaboration Awards